Early Detection of Cognitive Dysfunction in Diabetes

Study of Cognitive Dysfunction and Diabetes

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01830998

Enrollment

400

Registered

2013-04-12

Start date

2012-01-31

Completion date

2014-12-31

Last updated

2014-12-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dementia, DM, MCI

Keywords

Dementia, Olfactory

Brief summary

The rate of cognitive decline due to ageing is increased 1.5-fold to 2.0-fold in individuals with type 2 diabetes.There are no established specific treatment measures to prevent or ameliorate cognitive impairments in patients with diabetes. we want to detecte early clinical dementia in diabete.

Detailed description

Clinically relevant cognitive decrements in relation to diabetes mainly occur during two crucial periods in life: the period of brain development in childhood, and the period when the brain undergoes neurodegenerative changes associated with ageing.Potential leads for treatment are to optimise glycaemic control and avoid and treat vascular risk factors.we want to detecte early clinical dementia in diabete by MMSE and Olfactory function.

Interventions

None listed

Study design

Observational model

CASE_CONTROL

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

50 Years to 80 Years

Healthy volunteers

Yes

Inclusion criteria

* Patients with type 2 diabetes(Age\>50 years)

Exclusion criteria

* with stroke or other complications.

Design outcomes

Primary

Measure	Time frame	Description
MMSE Olfactory function dementia	2 years	MMSE,Olfactory function and PET(fMRI) were observed.

Countries

China

Contacts

Primary Contactxuzhipeng Wuqiang lihonghua, doctor

21823074@qq.com13871168392

Outcome results